- Biocon Limited has announced the approval of several related party transactions through postal ballot.
- The resolutions were passed with a majority vote on 22nd September 2024.
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.
Learn MoreBIOCON PRIOR FILINGS
- 2h ago
- 1d ago
- 2d ago
- 2d ago
- 6d ago
Biocon Biologics To Highlight Expanding Product Pipeline At J.P. Morgan Healthcare Conference
Biocon Engages Institutional Investor Quest Investment Advisors in Virtual Meeting, No UPSI Disclos…
Biocon Biologics Marks One Year as Global Biosimilars Leader, Surpassing $1 Billion in Revenue and …
Biocon Gets Approval for Ustekinumab BS Biosimilar in Japan, Expanding Global Presence
Biocon To Hold Q3 FY 2024-25 Earnings Call on January 31, Trading Window Closed Until February 1
ALL LATEST FILINGS
- 23m ago
- 2h ago
- 2h ago
- 2h ago
- 2h ago
TCS Reports Q3 FY25 Earnings With Standalone And Consolidated Results Approved By Board
Adani Total Gas Gets 20% Upward Revision in APM Gas Allocation Effective January 16, 2025
Biocon Biologics To Highlight Expanding Product Pipeline At J.P. Morgan Healthcare Conference
TCS Appoints Four New Senior Management Personnel to Drive Growth Across Key Markets
ONGC Appoints Five New Executive Directors to Strengthen Senior Management Team